Germline variation in colorectal risk Loci does not influence treatment effect or survival in metastatic colorectal cancer.
<h4>Background</h4>Colorectal cancer (CRC) risk is partly conferred by common, low-penetrance single nucleotide polymorphisms (SNPs). We hypothesized that these SNPs are associated with outcomes in metastatic CRC.<h4>Methods</h4>Six candidate SNPs from 8q24, 10p14, 15q13, 18q...
Saved in:
| Main Authors: | Hanna K Sanoff, Lindsay A Renfro, Pradeep Poonnen, Pratibha Ambadwar, Daniel J Sargent, Richard M Goldberg, Howard McLeod |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0094727 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Germline genomic profiling of patients with early-onset colorectal cancer
by: G. Mauri, et al.
Published: (2025-06-01) -
Germline variants in patients from the Iranian hereditary colorectal cancer registry
by: Lena Goshayeshi, et al.
Published: (2025-04-01) -
Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample.
by: Heather Spencer Feigelson, et al.
Published: (2014-01-01) -
Does sex of the patient play a role in survival for MSI colorectal cancer?
by: Adrian Tulin, et al.
Published: (2018-04-01) -
Colorectal Cancer with Uncommon Metastatic Spread
by: Luca Dellavedova, et al.
Published: (2015-07-01)